TipRanks

David Charles Lubner Insider Profile

4 Followers
David Charles Lubner, Director at Braveheart Bio, Inc., holds 55.55K shares in Braveheart Bio, Inc. (Ticker: BRVE), holds 0.00 shares in Dyne Therapeutics (Ticker: DYN), holds 0.00 shares in Arcellx Inc (Ticker: ACLX). Most recently, David Charles Lubner Bought ― shares of Braveheart Bio, Inc. on Aug 07, 2026 for an estimated value of $999.99K.
tipranks
David Charles Lubner

David Charles Lubner
Braveheart Bio, Inc. (BRVE)
Director

Ranked #17,472 out of 109,349 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+57.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
100.00%
0.00%
0.00%
0.00%
0.00% Others
A breakdown of David Charles Lubner's holdings

Insider Roles

Braveheart Bio, Inc.
(BRVE)
Director
Dyne Therapeutics
(DYN)
Director
Vor Biopharma
(VOR)
Director
Disc Medicine
(IRON)
Director
+1 other positions
Roles that David Charles Lubner holds in companies

Most Profitable Insider Trade

Stock:
POINT Biopharma Global
(PNT)
Rating:Informative Buy
Date:Nov 28, 2022 - Nov 28, 2023
Return:+109.50%
The most profitable trade made by David Charles Lubner

David Charles Lubner's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Braveheart Bio, Inc.
Aug 07, 2026
Director
Informative Buy
999.99K
$1.19M
TTPH
Tetraphase
Aug 17, 2015
―
Uninformative Sell
407.74K
$157.94K
RARX
Ra Pharmaceuticals
Apr 03, 2020
―
Uninformative Sell
749.86K
$0.00
~NITE
Nightstar Therapeutics Limited
Jun 07, 2019
―
Uninformative Sell
742.66K
$0.00
Dyne Therapeutics
Apr 28, 2026
Director
Uninformative Sell
―
$0.00
Vor Biopharma
―
Director
―
―
Disc Medicine
―
Director
―
―
PNT
POINT Biopharma Global
Dec 27, 2023
―
Uninformative Sell
―
$0.00
ACLX
Arcellx Inc
Apr 28, 2026
―
Uninformative Sell
―
$0.00
CRGX
CARGO Therapeutics, Inc.
―
―
―
―
Crescent Biopharma
―
Director
―
―
List of latest transactions for each holding click on a transaction to see David Charles Lubner's performance on stock

David Charles Lubner insider profile FAQ

What is the percentage of profitable transactions made by David Charles Lubner?
The percentage of profitable transactions made by David Charles Lubner is 67%.
    What is the average return per transaction made by David Charles Lubner?
    The average return per transaction made by David Charles Lubner is 57.20%.
      What stocks does David Charles Lubner hold?
      David Charles Lubner holds: BRVE, TTPH, RARX, ~NITE, DYN, VOR, IRON, PNT, ACLX, CRGX, CBIO stocks.
        What was David Charles Lubner’s latest transaction?
        David Charles Lubner latest transaction was an Informative Buy of $999.99K.
          What was David Charles Lubner's most profitable transaction?
          David Charles Lubner’s most profitable transaction was an Informative Buy of PNT stock on November 28, 2022. The return on the trade was 109.50%.
            What is David Charles Lubner's role in Braveheart Bio, Inc.?
            David Charles Lubner's role in Braveheart Bio, Inc. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.